There are no clear guidelines regarding screening of digestive cancers in BRCA2 carriers and even for pancreatic cancer screening (part of both the BRCA1 and BRCA2 phenotype [33]) the recommendation is to include those carriers in prospective studies [44]. The gene discussed is BRCA2; the disease is pancreatic neoplasm.